Great tip! Thanks so much for posting about this Mango. There is a really interesting snippet right immediately before that as well, where she says that they are seeing higher use of glycolysis in naive B cells in patients (4.06.25) and they are just working that up now. Could that tie in with the paper just out from Stanford re: levels of ATP I wonder?If you're interested in Jo Cambridge's personal opinions about Rituximab and people's attitude towards her research etc, make sure to keep listening when they take a break in the afternoon, after Julin's second presentation, before Ewa W-W's presentation.
(If they haven't edited that part out. I don't think she was aware that the mic was still on..!)